Beruflich Dokumente
Kultur Dokumente
Legislative Advertising: Pharmacy Choice & Access Now, P.O. Box 3435, Arlington, VA 22203, Richard Beck, Board Member
Table of Contents
Highlights of Study Findings ....................................................................................1
The Perryman Group’s Perspective ..........................................................................5
Assumptions and Analysis in Support of Various Plans for Change .....................9
Proposed Change Scenarios ....................................................................................13
Measuring the Economic Impacts .........................................................................14
Economic Impact Results .......................................................................................16
Scenario I: THHSC “Carve-In” Plan with Network Access Restriction ............................... 16
Scenario II: Fee Reductions as Proposed in the Texas Legislature ...................................... 20
Scenario III: Dispensing Fee Policy Changes as Outlined by The Lewin Group ................. 22
APPENDICES............................................................................................ 28
APPENDIX A: US Multi-Regional Impact Assessment System Methodology .29
APPENDIX B: Detailed Sectoral Results ..............................................................34
Scenario I: THHSC “Carve-In” Plan with Network Restriction ........................................... 35
Scenario II: Fee Reductions as Proposed in the Texas Legislature ...................................... 48
Scenario III: Dispensing Fee Policy Changes as Outlined by The Lewin Group ............... 61
i
INTRODUCTION
1
The network of pharmacies is crucial to ensuring adequate access for
both Medicaid and non-Medicaid patients, and pharmacy closures
would affect both groups. If access to needed medications is
constrained, additional health care outlays occur (which impose
incremental burdens on the State government), as well as other
economic disruptions.
Scenario I assumes the plan recently put forth by the Texas Health and
Human Services Commission (THHSC) is put in place (along with fee
reductions currently proposed by the Texas Legislature).
o This cost-reduction plan and the likely associated network
limitations have the potential to cause notable harms to the
pharmacy sector including the loss of more than 770
(primarily independent and small chain) locations, nearly
$1.6 billion in annual output (gross product) and 22,135 jobs.
o Access to needed medications is also reduced, affecting both
Medicaid and non-Medicaid patients. The total negative
effect (including these pharmacy losses and incremental
outlays for health care among Medicaid and non-Medicaid
patients) includes $3.1 billion in annual output and 42,923
permanent jobs. Because of the disproportionate number of
recipients in the blind and disabled category, these effects
could well be even larger.
o In addition, these losses in business activity reduce tax receipts
to the State (as well as local governments) and generate a need
for higher future spending due to increased health care needs.
The Perryman Group estimates the losses in State tax revenue
(when measured on a dynamic basis) to be $719.1 million in
yearly dynamic State revenue losses and required outlays.
2
These losses are far larger than any alleged benefits
associated with any incremental premium taxes.
o Looking beyond even the health outcomes, the network
limitations of mental health patients also lead to adverse
economic consequences in the form of increased
homelessness, incarceration, comorbidities, mortality, and
unemployment rates, as well as decreases in productivity.
These phenomena lead to an annual loss of about $3.8 billion
in output and more than 46,500 jobs.
3
o Within the pharmacy sector, such a scenario leads to losses
of more than 1,150 pharmacies, as well as almost $2.4 billion
in annual output and 33,330 jobs.
o Overall losses under this scenario (including pharmacy
losses and incremental outlays by patients associated with
the potential network reductions) were estimated to be $4.7
billion in output and 64,632 jobs.
o Yearly State revenue losses and expenditure increases were
found to total about $1.8 billion. If the reductions were also
accompanied by additional network reductions (as would be
anticipated in the approach suggested in the Lewin study), the
aggregate losses would be even greater.
4
access would involve substantial negative fallout and should be
evaluated within a framework that fully reflects the overall
consequences of policy changes. While the additional strain on the
State budget is dynamic in nature and not always measured in the
framework of policy debates, it is nonetheless very real (as are the
associated costs to the economy and overall health and well-being
of Texas citizens).
TPG has completed scores of impact analyses related to health care and
the life sciences. Some representative examples include studies of The
Texas Institute for Preclinical Studies, The Texas Institute for Genomic
Medicine, the proposed University of Texas Medical School in Austin,
the Galveston National Laboratory for Infectious Diseases at the
University of Texas Medical Branch, the proposed Center for
Translational Medicine in Round Rock, Parkland Hospital, the
5
Methodist Hospital, University Health System, M. D. Anderson Cancer
Center, Texas Tech Health Science Center, all of the hospitals in the
VHA Southwest system, Citizens Medical Center, Scott & White
(Temple Health and Bioscience District), the University of Texas
Health Science Center at San Antonio, Baylor College of Medicine,
Texas Medical Center, the University of Kansas Medical Center, and
numerous entities engaged in the development and production of
biomedical products.
6
PROVIDING PHARMACY BENEFITS
FOR TEXAS MEDICAID PATIENTS
7
Recently, proposals have surfaced to change to a “carve-in”
mechanism for funding.
o A “carve-in” structure involves shifting pharmacy benefits to
be included within the role of the MCOs, which contract with
the State to provide health services for Medicaid programs for a
set capitated cost.
o With pharmacy benefits “carved in,” MCOs would likely contract
with a PBM, a for-profit firm which acts as administrator of
the prescription drug program.
o Proponents point to potential savings due to efficiencies under the
“carve-in” system. However, many of these alleged advantages
are illusory. Moreover, if such an approach is adopted, it is
critical that a broad network of providers be preserved, which
typically does not occur in a managed care model.
8
Assumptions and Analysis in Support of Various Plans
for Change
As a part of this assessment, The Perryman Group examined various
studies and analyses pertaining to cost-reduction proposals.
9
comparative analysis. This phenomenon alone could more than offset
the purported savings from the “carve-in” model.
10
First, the majority of the savings is achieved through a dramatic
reduction in fees that would reduce them to less than 20% of the actual
cost of dispensing medications. A decrease of this magnitude would
dramatically impact the viability of the Texas pharmacy sector and
have enormous adverse consequences, essentially dismantling much of
the existing pharmacy infrastructure of the state. In fact, THHSC has
previously conducted extensive analysis to demonstrate the
reasonableness of the current fee structure. Moreover, changes in fees
can be (and, in fact, recently have been) implemented within the
current structure. The economic impact of such an approach is
outlined below.
11
Coordination Organizations—The Experience of Medicaid Managed
Care Programs for People with Disabilities, Center for Health Care
Strategies, Inc., April 2006).
Thus, the findings from the Lewin study are not a reliable barometer of
the current environment in Texas and do not form an appropriate
mechanism for policy determination.
12
RESULTS OF THE IMPACT ANALYSIS
Pharmacy closures and a reduction in access would affect not only the
Medicaid population, but also non-Medicaid patients.
13
Measuring the Economic Impacts
The Perryman Group first analyzed the effect on pharmacies of various
cost-reduction proposals and found that pharmacy store closings would
likely occur.
14
Impacts are expressed in terms of several different measures of
business activity.
o Total expenditures (or total spending) measures the reduction in
dollars changing hands in the state as a result of the reduced
access.
o Gross product (or output) is the reduction in production of
goods and services that will come about in Texas as a result of
the changes. This measure is parallel to the gross domestic
product numbers commonly reported by various media outlets
and is a subset of total expenditures.
o Personal income is dollars that end up in the hands of people in
the area; the vast majority of this aggregate derives from the
earnings of employees, but payments such as interest and rents
are also included.
o Job losses are expressed as permanent jobs (given that this will
be an ongoing impact).
Key results for each scenario are presented below; additional detail by
industrial segment is presented in Appendix B of this report.
15
Economic Impact Results
16
In addition, access to needed medications is also reduced. As noted,
both Medicaid and non-Medicaid patients are affected. A substantial
component of the overall costs stems from the area of mental health
care.
17
The following table breaks down the sources of these losses.
TOTAL PHARMACY
AND
$5,630.904 $3,130.390 $1,974.463 42,923
INCREMENTAL
HEALTH CARE
COSTS
18
outlays. These losses are far larger than any alleged benefits
associated with any incremental premium taxes.
19
Scenario II: Fee Reductions as Proposed in the Texas Legislature
20
The total negative effect on the pharmacy and health care for all
patients under these assumptions includes $722.3 million in lost output
(gross product) each year and 9,904 permanent jobs.
21
The table below presents a breakout of these losses.
TOTAL
$305.707 $163.165 $107.387 2,187
TOTAL
$364.853 $194.734 $128.163 2,610
TOTAL PHARMACY
AND
INCREMENTAL $1,299.258 $722.297 $455.582 9,904
HEALTH CARE
COSTS
22
If the dispensing fee policy as outlined by The Lewin Group is
implemented, the reduction in business activity in the state would be
even more significant. Within the pharmacy sector, such a scenario
leads to losses of more than 1,150 pharmacies, as well as almost $2.4
billion in annual output and 33,330 jobs.
23
Overall losses under this scenario (including pharmacy losses and
incremental outlays by patients associated with the potential
network reductions) were estimated to be $4.7 billion in output and
64,632 jobs.
-64,632
Permanent -$2.973 Personal Income
Jobs
-$10 -$9 -$8 -$7 -$6 -$5 -$4 -$3 -$2 -$1 $0
Billions of 2010 Dollars
Note: Includes Medicaid and Non-Medicaid patients as well as both mental and general health care. Assumes that the access effects
on the general population will only be 20% as significant as those for Medicaid recipients.
Source: The Perryman Group
24
The Annual Impact of the Potential Network Reductions Accompanying
Implementing the Dispensing Fee Policy Recommendations of the
Lewin Study on Business Activity in Texas (as of 2013)
(All Monetary Values are Given in Millions of 2010 Dollars)
Total Output (Gross Personal
Employment
Expenditures Product) Income
Losses in the Pharmacy $4,102.873 $2,378.058 $1,435.924 33,330
Sector
Total Incremental Cost
for Mental and General $4,376.076 $2,335.647 $1,537.199 31,302
Health Care for All
Patients
Incremental Cost for Mental $811.301 $435.180 $263.034 5,950
Health Care for Health
Medicaid Patients General $1,183.743 $629.637 $437.772 8,321
Health
TOTAL $1,995.044 $1,064.816 $700.806 14,271
TOTAL PHARMACY
AND
$8,478.949 $4,713.705 $2,973.124 64,632
INCREMENTAL
HEALTH CARE
COSTS
25
CONCLUSION
In addition, such closures would lead to higher costs for Medicaid and
non-Medicaid patients. Restricting network access through a plan such
as that proposed by the THHSC would lead to losses of an estimated
$3.1 billion in output (gross product) and 42,923 jobs by 2013. Other
26
non-medical costs (such as increased homelessness and incarceration)
would likely be realized.
27
APPENDICES
28
APPENDIX A: US Multi-Regional Impact
Assessment System Methodology
29
US Multi-Regional Impact Assessment System
30
non-Medicaid population, although likely to a lesser extent. TPG assumed the
non-Medicaid population would be affected in relative terms by 20% of the level of
the Medicaid population. Given the demographics of Texas, this level almost
certainly understates the likely effects.
• TPG further examined the other, non-medical outcomes from reducing access to
mental health care. This analysis is derived from a prior study of the overall cost of
mental health and substance abuse in Texas, with all values fully updated for
subsequent price and demographic changes (Costs, Consequences and Cures!!!
An Assessment of the Impact of Severe Mental Health and Substance Abuse
Disorders on Business Activity in Texas and the Anticipated Economic and Fiscal
Return on Investment in Expanded Mental Health Services, May 2009). This study
examined comorbidities, disabilities, income, productivity, unemployment,
incarceration, homelessness, and mortality, all of which are well-documented
aspects of mental illness.
• The second step is the simulation of the input-output system to measure overall
economic effects. In the case of a prospective evaluation, it is necessary to first
calculate reasonable estimates of the direct activity (as described above).
• Once the direct input values were determined, the present study was conducted
within the context of the US Multi-Regional Impact Assessment System
(USMRIAS) which was developed and is maintained by The Perryman Group.
This model has been used in hundreds of diverse applications across the country
and has an excellent reputation for accuracy and credibility. In addition, the model
has been in operation and continually updated for over two decades. The system
used in the current simulations reflects the unique industrial structure of Texas.
• The USMRIAS is somewhat similar in format to the Input-Output Model of the
United States and the Regional Input-Output Modeling System, both of which are
maintained by the US Department of Commerce. The model developed by TPG,
however, incorporates several important enhancements and refinements.
Specifically, the expanded system includes (1) comprehensive 500-sector
coverage for any county, multi-county, or urban region; (2) calculation of both total
expenditures and value-added by industry and region; (3) direct estimation of
expenditures for multiple basic input choices (expenditures, output, income, or
employment); (4) extensive parameter localization; (5) price adjustments for real
and nominal assessments by sectors and areas; (6) measurement of the induced
impacts associated with payrolls and consumer spending; (7) embedded modules
to estimate multi-sectoral direct spending effects; (8) estimation of retail spending
activity by consumers; and (9) comprehensive linkage and integration capabilities
with a wide variety of econometric, real estate, occupational, and fiscal impact
models. The models used for the present investigation have been thoroughly
tested for reasonableness and historical reliability.
• As noted earlier, the impact assessment (input-output) process essentially
estimates the amounts of all types of goods and services required to produce one
unit (a dollar’s worth) of a specific type of output. For purposes of illustrating the
nature of the system, it is useful to think of inputs and outputs in dollar (rather than
physical) terms. As an example, the construction of a new building will require
31
specific dollar amounts of lumber, glass, concrete, hand tools, architectural
services, interior design services, paint, plumbing, and numerous other elements.
Each of these suppliers must, in turn, purchase additional dollar amounts of inputs.
This process continues through multiple rounds of production, thus generating
subsequent increments to business activity. The initial process of building the
facility is known as the direct effect. The ensuing transactions in the output chain
constitute the indirect effect.
• Another pattern that arises in response to any direct economic activity comes from
the payroll dollars received by employees at each stage of the production cycle.
As workers are compensated, they use some of their income for taxes, savings,
and purchases from external markets. A substantial portion, however, is spent
locally on food, clothing, healthcare services, utilities, housing, recreation, and
other items. Typical purchasing patterns in the relevant areas are obtained from
the ACCRA Cost of Living Index, a privately compiled inter-regional measure
which has been widely used for several decades, and the Consumer Expenditure
Survey of the US Department of Labor. These initial outlays by area residents
generate further secondary activity as local providers acquire inputs to meet this
consumer demand. These consumer spending impacts are known as the induced
effect. The USMRIAS is designed to provide realistic, yet conservative, estimates
of these phenomena.
• Sources for information used in this process include the Bureau of the Census, the
Bureau of Labor Statistics, the Regional Economic Information System of the US
Department of Commerce, and other public and private sources. The pricing data
are compiled from the US Department of Labor and the US Department of
Commerce. The verification and testing procedures make use of extensive public
and private sources. Note that all monetary values, unless otherwise noted, are
given in constant (2010) dollars to eliminate the effects of inflation.
• The USMRIAS generates estimates of the effect on several measures of business
activity. The most comprehensive measure of economic activity used in this study
is Total Expenditures. This measure incorporates every dollar that changes
hands in any transaction. For example, suppose a farmer sells wheat to a miller
for $0.50; the miller then sells flour to a baker for $0.75; the baker, in turn, sells
bread to a customer for $1.25. The Total Expenditures recorded in this instance
would be $2.50, that is, $0.50 + $0.75 + $1.25. This measure is quite broad, but is
useful in that (1) it reflects the overall interplay of all industries in the economy, and
(2) some key fiscal variables such as sales taxes are linked to aggregate
spending.
• A second measure of business activity frequently employed in this analysis is that
of Gross Product. This indicator represents the regional equivalent of Gross
Domestic Product, the most commonly reported statistic regarding national
economic performance. In other words, the Gross Product of, say, Amarillo is the
amount of US output that is produced in that area. It is defined as the value of all
final goods produced in a given region for a specific period of time. Stated
differently, it captures the amount of value-added (gross area product) over
intermediate goods and services at each stage of the production process, that is, it
32
eliminates the double counting in the Total Expenditures concept. Using the
example above, the Gross Product is $1.25 (the value of the bread) rather than
$2.50. Alternatively, it may be viewed as the sum of the value-added by the
farmer, $0.50; the miller, $0.25 ($0.75 - $0.50); and the baker, $0.50 ($1.25 -
$0.75). The total value-added is, therefore, $1.25, which is equivalent to the final
value of the bread. In many industries, the primary component of value-added is
the wage and salary payments to employees.
• The third gauge of economic activity used in this evaluation is Personal Income.
As the name implies, Personal Income is simply the income received by
individuals, whether in the form of wages, salaries, interest, dividends, proprietors’
profits, or other sources. It may thus be viewed as the segment of overall impacts
which flows directly to the citizenry.
• The fourth measure, Retail Sales, represents the component of Total
Expenditures which occurs in retail outlets (general merchandise stores,
automobile dealers and service stations, building materials stores, food stores,
drugstores, restaurants, and so forth). Retail Sales is a commonly used measure
of consumer activity.
• The final aggregates used are Permanent Jobs and Person-Years of
Employment. The Person-Years of Employment measure reveals the full-time
equivalent jobs generated by an activity. A person-year is simply the equivalent of
a person working for a year. As an example, it could be a carpenter employed for
five months, a mason for three months, and a painter for four months. In the case
of a construction project, these are typically spread over the course of the
construction and development phase. It should be noted that, unlike the dollar
values described above, Permanent Jobs is a “stock” rather than a “flow.” In other
words, if an area produces $1 million in output in 2007 and $1 million in 2008, it is
appropriate to say that $2 million was achieved in the 2007-2008 period. If the
same area has 100 people working in 2007 and 100 in 2008, it only has 100
Permanent Jobs. When a flow of jobs is measured, such as in a construction
project or a cumulative assessment over multiple years, it is appropriate to
measure employment in Person-Years (a person working for a year). This concept
is distinct from Permanent Jobs, which anticipates that the relevant positions will
be maintained on a continuing basis.
• The fiscal effects are derived from a model which translates changes in various
measures of economic activity into the tax structure of Texas. The incremental
direct outlays for health care expenses paid through State programs are also
included.
33
APPENDIX B: Detailed Sectoral Results
34
Scenario I: THHSC “Carve-In” Plan with
Network Restriction
35
The Annual Impact of the Losses in the Pharmacy Sector Associated with the Potential
Network Reductions Accompanying a "Carve-In" Approach to Medicaid Prescription
Management on Business Activity in Texas (as of 2013)
Detailed Industrial Category
36
The Annual Impact of Incremental Outlays for Mental Health Care Among Medicaid
Patients Associated with the Potential Network Reductions Accompanying a
"Carve-In" Approach to Medicaid Prescription Management on Business Activity in
Texas (as of 2013)
Detailed Industrial Category
37
The Annual Impact of Incremental Outlays for General Health Care (Excluding Mental
Health) Among Medicaid Patients Associated with the Potential Network Reductions
Accompanying a "Carve-In" Approach to Medicaid Prescription Management on
Business Activity in Texas (as of 2013)
Detailed Industrial Category
38
The Total Annual Impact of Incremental Outlays for Health Care (Mental Health and
General) Among Medicaid Patients Associated with the Potential Network Reductions
Accompanying a "Carve-In" Approach to Medicaid Prescription Management on
Business Activity in Texas (as of 2013)
Detailed Industrial Category
39
The Annual Impact of Incremental Outlays for Mental Health Care Among Non -Medicaid
Patients Associated with the Potential Network Reductions Accompanying a "Carve -In"
Approach to Medicaid Prescription Management
on Business Activity in Texas (as of 2013)
Detailed Industrial Category
40
The Annual Impact of Incremental Outlays for General Health Care (Excluding Mental
Health) Among Non-Medicaid Patients Associated with the Potential Network
Reductions Accompanying a "Carve-In" Approach to Medicaid Prescription
Management on Business Activity in Texas (as of 2013)
Detailed Industrial Category
41
The Total Annual Impact of Incremental Outlays for Health Care (Mental Health and
General) Among Non-Medicaid Patients Associated with the Potential Network
Reductions Accompanying a "Carve-In" Approach to Medicaid Prescription
Management on Business Activity in Texas (as of 2013)
Detailed Industrial Category
42
The Total Annual Impact of Incremental Outlays for Health Care (Mental Health and
General) Among All Patients (Medicaid and Non-Medicaid) Associated with the Potential
Network Reductions Accompanying a "Carve-In" Approach to Medicaid Prescription
Management on Business Activity in Texas
(as of 2013)—Detailed Industrial Category
43
The Total Annual Impact of Pharmacy Losses and Incremental Outlays for Health Care
(Mental Health and General) Among All Patients (Medicaid and Non-Medicaid)
Associated with the Potential Network Reductions Accompanying a "Carve -In"
Approach to Medicaid Prescription Management on Business Activity in Texas (as of
2013)—Detailed Industrial Category
44
The Annual Impact of the Consequences Other than Direct Medical Costs (such as
Homelessness, Incarceration, Unemployment, and Loss of Productivity) Resulting from
Limitations on Mental Heath Care Access Among Medicaid Patients Associated with the
Potential Network Reductions Accompanying a "Carve-In" Approach to Medicaid
Prescription Management on Business Activity in Texas (as of 2013)—Detailed
Industrial Category
45
The Annual Impact of the Consequences Other than Direct Medical Costs (such as
Homelessness, Incarceration, Unemployment, and Loss of Productivity) Resulting from
Limitations on Mental Heath Care Access Among Non-Medicaid Patients Associated
with the Potential Network Reductions Accompanying a "Carve-In" Approach to
Medicaid Prescription Management on Business Activity in Texas (as of 2013)—Detailed
Industrial Category
46
The Annual Impact of the Consequences Other than Direct Medical Costs
(such as Homelessness, Incarceration, Unemployment, and Loss of Productivity)
Resulting from Limitations on Mental Heath Care Access Among All Patients (Medicaid
and Non-Medicaid) Associated with the Potential Network Reductions Accompanying a
"Carve-In" Approach to Medicaid Prescription Management on Business Activity in
Texas (as of 2013)
Detailed Industrial Category
47
Scenario II: Fee Reductions as Proposed in
the Texas Legislature
48
The Annual Impact of the Losses in the Pharmacy Sector Associated
with the Dispensing Fee Reductions Currently Proposed on Business Activity
in Texas (as of 2013)
Detailed Industrial Category
49
The Annual Impact of Incremental Outlays for Mental Health Care Among Medicaid
Patients Associated with the Dispensing Fee Reductions Currently Proposed on
Business Activity in Texas (as of 2013)
Detailed Industrial Category
50
The Annual Impact of Incremental Outlays for General Health Care (Excluding Mental
Health) Among Medicaid Patients Associated with the Dispensing Fee Reductions
Currently Proposed on Business Activity in Texas (as of 2013)
Detailed Industrial Category
51
The Total Annual Impact of Incremental Outlays for Health Care (Mental Health and
General) Among Medicaid Patients Associated with the Dispensing Fee Reductions
Currently Proposed on Business Activity in Texas (as of 2013)
Detailed Industrial Category
52
The Annual Impact of Incremental Outlays for Mental Health Care Among Non -Medicaid
Patients Associated with the Dispensing Fee Reductions Currently Proposed on
Business Activity in Texas (as of 2013)
Detailed Industrial Category
53
The Annual Impact of Incremental Outlays for General Health Care (Excluding Mental
Health) Among Non-Medicaid Patients Associated with the Dispensing Fee Reductions
Currently Proposed on Business Activity in Texas
(as of 2013)—Detailed Industrial Category
54
The Total Annual Impact of Incremental Outlays for Health Care (Mental Health and
General) Among Non-Medicaid Patients Associated with the Dispensing Fee Reductions
Currently Proposed on Business Activity in Texas (as of 2013)
Detailed Industrial Category
55
The Total Annual Impact of Incremental Outlays for Health Care (Mental Health and
General) Among All Patients (Medicaid and Non-Medicaid) Associated with the
Dispensing Fee Reductions Currently Proposed on Business Activity
in Texas (as of 2013)—Detailed Industrial Category
56
The Total Annual Impact of Pharmacy Losses and Incremental Outlays for Health Care
(Mental Health and General) Among All Patients (Medicaid and Non -Medicaid)
Associated with the Dispensing Fee Reductions Currently Proposed on Business
Activity in Texas (as of 2013)—Detailed Industrial Category
57
The Annual Impact of the Consequences Other than Direct Medical Costs
(such as Homelessness, Incarceration, Unemployment, and Loss of Productivity)
Resulting from Limitations on Mental Heath Care Access Among Medicaid Patients
Associated with the Dispensing Fee Reductions Currently Proposed on Business
Activity in Texas (as of 2013)
Detailed Industrial Category
58
The Annual Impact of the Consequences Other than Direct Medical Costs
(such as Homelessness, Incarceration, Unemployment, and Loss of Productivity)
Resulting from Limitations on Mental Heath Care Access Among Non -Medicaid Patients
Associated with the Dispensing Fee Reductions Currently Proposed on Business
Activity in Texas (as of 2013)
Detailed Industrial Category
59
The Annual Impact of the Consequences Other than Direct Medical Costs
(such as Homelessness, Incarceration, Unemployment, and Loss of Productivity)
Resulting from Limitations on Mental Heath Care Access Among All Patients (Medicaid
and Non-Medicaid) Associated with the Dispensing Fee Reductions Currently Proposed
on Business Activity in Texas (as of 2013)
Detailed Industrial Category
60
Scenario III: Dispensing Fee Policy Changes
as Outlined by The Lewin Group
61
The Annual Impact of the Losses in the Pharmacy Sector Associated with
Implementing the Dispensing Fee Policy Recommendations of the Lewin Study
on Business Activity in Texas (as of 2013)
Detailed Industrial Category
62
The Annual Impact of Incremental Outlays for Mental Health Care Among
Medicaid Patients Associated with the Pharmacy Network Effects of Implementing the
Dispensing Fee Policy Recommendations of the Lewin
Study on Business Activity in Texas (as of 2013)
Detailed Industrial Category
63
The Annual Impact of Incremental Outlays for General Health Care (Excluding
Mental Health) Among Medicaid Patients Associated with the Pharmacy
Network Effects of Implementing the Dispensing Fee Policy Recommendations
of the Lewin Study on Business Activity in Texas (as of 2013)
Detailed Industrial Category
64
The Total Annual Impact of Incremental Outlays for Health Care (Mental Health
and General) Among Medicaid Patients Associated with the Pharmacy
Network Effects of Implementing the Dispensing Fee Policy Recommendations
of the Lewin Study on Business Activity in Texas (as of 2013)
Detailed Industrial Category
65
The Annual Impact of Incremental Outlays for Mental Health Care Among
Non-Medicaid Patients Associated with the Pharmacy Network Effects
of Implementing the Dispensing Fee Policy Recommendations of the Lewin
Study on Business Activity in Texas (as of 2013)
Detailed Industrial Category
66
The Annual Impact of Incremental Outlays for General Health Care (Excluding
Mental Health) Among Non-Medicaid Patients Associated with the
Pharmacy Network Effects of Implementing the Dispensing Fee Policy
Recommendations of the Lewin Study on Business Activity in Texas
(as of 2013)—Detailed Industrial Category
67
The Total Annual Impact of Incremental Outlays for Health Care (Mental Health
and General) Among Non-Medicaid Patients Associated with the Pharmacy
Network Effects of Implementing the Dispensing Fee Policy Recommendations
of the Lewin Study on Business Activity in Texas (as of 2013)
Detailed Industrial Category
68
The Total Annual Impact of Incremental Outlays for Health Care (Mental Health
and General) Among All Patients (Medicaid and Non-Medicaid) Associated with
the Pharmacy Network Effects of Implementing the Dispensing Fee Policy
Recommendations of the Lewin Study on Business Activity in Texas
(as of 2013)—Detailed Industrial Category
69
The Total Annual Impact of Pharmaceutical Losses and Incremental Outlays
for Health Care (Mental Health and General) Among All Patients (Medicaid and
Non-Medicaid) Associated with the Pharmacy Network Effects of
Implementing the Dispensing Fee Policy Recommendations of the Lewin
Study on Business Activity in Texas (as of 2013)—Detailed Industrial Category
70
The Annual Impact of the Consequences Other than Direct Medical Costs
(such as Homelessness, Incarceration, Unemployment, and Loss of
Productivity) Resulting from Limitations on Mental Heath Care Access Among
Medicaid Patients Associated with the Pharmacy Network Effects of
Implementing the Dispensing Fee Policy Recommendations of the Lewin Study
on Business Activity in Texas (as of 2013)—Detailed Industrial Category
71
The Annual Impact of the Consequences Other than Direct Medical Costs
(such as Homelessness, Incarceration, Unemployment, and Loss of
Productivity) Resulting from Limitations on Mental Heath Care Access Among
Non-Medicaid Patients Associated with the Pharmacy Network Effects
of Implementing the Dispensing Fee Policy Recommendations of the Lewin
Study on Business Activity in Texas (as of 2013)—Detailed Industrial Category
72
The Annual Impact of the Consequences Other than Direct Medical Costs
(such as Homelessness, Incarceration, Unemployment, and Loss of
Productivity) Resulting from Limitations on Mental Heath Care Access Among
All Patients (Medicaid and Non-Medicaid) Associated with the Pharmacy
Network Effects of Implementing the Dispensing Fee Policy Recommendations
of the Lewin Study on Business Activity in Texas (as of 2013)
Detailed Industrial Category
73
www.rxchoiceandaccess.com www.perrymangroup.com